India Vaccination

National Vaccination Day celebrates Pulse Polio Immunization Programme launched in 1995 to fight a disease that has now been eradicated in the country

Acceptance of COVID-19 vaccines increased globally, from 75.2 per cent in 2021 to 79.1 per cent in 2022, according to a survey in 23 countries that represent more than 60 per cent of the world's population. The study underlines a wide variability among countries and the need for tailored communication strategies in addressing vaccine hesitancy. It was led by the Barcelona Institute for Global Health (ISGlobal), Spain, and the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), US. However, vaccine acceptance decreased in eight countries and almost one in eight vaccinated respondents, particularly younger men and women, were hesitant about receiving a booster dose, the study said. The findings have been published in Nature Medicine. "The pandemic is not over, and authorities must urgently address vaccine hesitancy and resistance as part of their COVID-19 prevention and mitigation strategy," says Jeffrey V Lazarus, Head of the Health Systems ...

Demand for flu vaccine weak in India; US facing worst season in a decade

With over 90% of population being vaccinated, it is okay at a policy level to relax the mandatory vaccination norm for entering India, they say

The requirement of random post-arrival testing of 2 per cent of arriving passengers too has been done away with in the new guideline

Firm is develop recombinant products in hormones, eyes acquisitions in South East Asia

One dose of vaccine has proven effective in stopping outbreaks, even though evidence on the exact duration of protection is 'limited'.

Covid-19 vaccine makers have no plans to seek further shelf life extensions

The 75-day-long Amrit Mahotsav campaign also helped salvage wastage of vaccine doses

Will be critical to the success of India's drive to eliminate TB by 2025

The locally developed Ceravac can play a critical role in the efficacy of the National Immunisation Mission

Due to the constantly emerging new Covid-19 variants, the currently available vaccines may not be as effective

Denial of doses to persons without IDs, absence of segregated data and low awareness pose question mark on campaign

In a Q&A, Rehan A Khan talks about his firm's strong focus on R&D and its commitment to making drugs affordable

Covaxin has a shelf life of 12 months, while Covishield, the vaccine that accounted for nearly 80% of India's vaccinations, has a shelf life of nine months

'Vaccine equity not possible if we include imported mRNA vaccines in our programme', said Arora

On May 4, Biological E submitted an application seeking emergency use authorisation for its Covid vaccine Corbevax as a booster dose in adults fully vaccinated with Covishield or Covaxin

A study found that a booster shot different from the primary vaccines, such as Covishield or Covaxin, did not produce satisfactory results

DCGI has granted emergency use authorisation for Biological E's Covid-19 vaccine Corbevax and Bharat Biotech's Covaxin

With 2,483 new coronavirus infections being reported in a day, India's total tally of COVID-19 cases rose to 4,30,62,569, while the active cases dipped to 15,636.